封面
市场调查报告书
商品编码
1085427

计算生物学的全球市场:各类型(细胞、生物模拟,疾病建模、模拟应用),各工具,各地区-规模,占有率,展望,机会分析(2022年~2028年)

Computational Biology Market, By Type (Cellular & Biological Simulation, Disease Modeling and Simulation Applications ), By Tools, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

生物资讯学工具的利用增加与研究开发的投资增加,预计促进在预测期间内的市场成长。再加上罹患慢性疾病的患者增加,及资料保存采用云端运算,也预计促进市场成长。

本报告提供全球计算生物学市场的相关调查,市场展望,市场动态,市场分析,竞争情形等全面性资讯。

目录

第1章 调查目的、前提条件

第2章 市场展望

  • 报告的说明
    • 市场定义和范围
  • 摘要整理
    • 市场明细:各类型
    • 市场明细:各工具
    • 市场明细:各地区
    • Coherent Opportunity Map(COM)

第3章 市场动态,法规,及趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场机会
  • 影响分析
  • 主要的焦点
  • 产品销售
  • PEST分析
  • 技术的进步
  • 法规情境
  • 合併和收购

第4章 全球计算生物学市场:各类型(100万美元)(2017年~2028年)

  • 简介
  • 细胞、生物模拟
  • 疾病建模、模拟应用

第5章 全球计算生物学市场:各工具(100万美元)(2017年~2028年)

  • 简介
  • 目录/资料库
  • 分析软体和服务
  • IT基础设施(硬体设备)

第6章 全球计算生物学市场:各地区(100万美元)(2017年~2028年)

  • 简介
  • 北美
  • 南美
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第7章 竞争情形

  • 企业简介
    • Accelrys
    • Certara, LP
    • Chemical Computing Group Inc.
    • Compugen, ltd.
    • Entelos, Inc.(Rosa &Co. LLC)
    • Genedata AG
    • Insilico Biotechnology AG
    • Leadscope, Inc.
    • Nimbus Discovery LLC
    • Rhenovia Pharma SAS
    • Schrodinger
    • Simulation Plus, Inc.

第8章 Section

简介目录
Product Code: CMI3915

Computational Biology are used of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques in life sciences. Predictive modeling tools provide vital information for better streamlining of drug development process thus reducing time and increasing efficiency. Increasing use of bioinformatics tools along with increasing investment in research and development is expected to propel the market growth during the forecast period. Furthermore, increasing patient population suffering from chronic diseases, increasing adoption of cloud computing for data storage is also anticipated to assist the growth of the market during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Computational Biology market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Computational Biology market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Computational Biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Computational Biology market

Detailed Segmentation:

  • Global Computational Biology Market, By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
  • Global Computational Biology Market, By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
  • Global Computational Biology Market, By Region:
  • North America
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • Accelrys *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Certara, L.P.
  • Chemical Computing Group Inc.
  • Compugen, ltd.
  • Entelos, Inc. (Rosa & Co. LLC)
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope, Inc.
  • Nimbus Discovery LLC
  • Rhenovia Pharma SAS
  • Schrodinger
  • Simulation Plus, Inc.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Tools
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Computational Biology Market, By Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Cellular & Biological Simulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
  • Disease Modeling and Simulation Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Drug Discovery
    • Drug Development

5. Global Computational Biology Market, By Tools, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Content/Database
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Analysis Software & Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • IT Infrastructure (Hardware)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Computational Biology Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

  • Company Profiles
    • Accelrys
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Certara, L.P.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Chemical Computing Group Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Compugen, ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Entelos, Inc. (Rosa & Co. LLC)
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Genedata AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Insilico Biotechnology AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Leadscope, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Nimbus Discovery LLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Rhenovia Pharma SAS
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Schrodinger
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Simulation Plus, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact